BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 11354768)

  • 1. Renal Safety of Iodinated Contrast Media Depending on Their Osmolarity - Current Outlooks.
    Mruk B
    Pol J Radiol; 2016; 81():157-65. PubMed ID: 27141236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iodinated contrast medium: Is there a re(n)al problem? A clinical vignette-based review.
    Lakhal K; Ehrmann S; Robert-Edan V
    Crit Care; 2020 Nov; 24(1):641. PubMed ID: 33168006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between Dilution Magnification of Non-Ionic Iodinated Contrast Medium and Amplification Effect of Radiation Dose.
    Imai K; Takeda K; Fujii K; Kawaura C; Nishimoto T; Mori M; Yamamoto Y; Izumi T
    J Neuroendovasc Ther; 2022; 16(12):586-592. PubMed ID: 37502666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast Media Adverse Drug Reactions in Highly Polluted Environment.
    Sauer N; Szlasa W; Jonderko L; Głowacka K; Karłowicz-Bodalska K; Wiela-Hojeńska A
    Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction between iodinated X-ray contrast agents and macrocyclic GBCAs provides a signal enhancement in T
    Di Gregorio E; Arena F; Gianolio E; Ferrauto G; Aime S
    Magn Reson Med; 2022 Jul; 88(1):357-364. PubMed ID: 35253921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iodine accumulation of the liver in patients treated with amiodarone can be unmasked using material decomposition from multiphase spectral-detector CT.
    Laukamp KR; Lennartz S; Hashmi A; Obmann M; Ho V; Große Hokamp N; Graner FP; Gilkeson R; Persigehl T; Gupta A; Ramaiya N
    Sci Rep; 2020 Apr; 10(1):6994. PubMed ID: 32332860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast enhancement efficacy of iodinated contrast media: Effect of molecular structure on contrast enhancement.
    Imai K; Ikeda M; Satoh Y; Fujii K; Kawaura C; Nishimoto T; Mori M
    Eur J Radiol Open; 2018; 5():183-188. PubMed ID: 30310828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of N-(2-hy-droxy-eth-yl)-5-nitro-isophthalamic acid monohydrate.
    Zou P; Wang HY; Luo SN; Liu YL; Shen YJ
    Acta Crystallogr Sect E Struct Rep Online; 2014 Nov; 70(Pt 11):o1205-6. PubMed ID: 25484831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethyl 3-carb-oxy-5-nitro-benzoate.
    Liu YL; Zou P; Xie MH; Luo SN; He YJ
    Acta Crystallogr Sect E Struct Rep Online; 2009 Apr; 65(Pt 5):o1174. PubMed ID: 21583976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methyl 3-carboxy-5-nitrobenzoate.
    Zou P; Xie MH; Luo SN; Liu YL; Shen YJ
    Acta Crystallogr Sect E Struct Rep Online; 2009 Jan; 65(Pt 2):o335. PubMed ID: 21581938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diethyl 5-amino-2,4,6-triiodo-isophthalate.
    Wu J; Xie MH; Zou P; Liu YL; He YJ
    Acta Crystallogr Sect E Struct Rep Online; 2009 Dec; 66(Pt 1):o10-1. PubMed ID: 21579990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimethyl 5-amino-2,4,6-triiodo-isophthalate.
    Zou P; Luo SN; Xie MH; Liu YL; Wu J
    Acta Crystallogr Sect E Struct Rep Online; 2010 Jan; 66(Pt 2):o360. PubMed ID: 21579785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current iodinated contrast media.
    Stacul F
    Eur Radiol; 2001; 11(4):690-7. PubMed ID: 11354768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Radiographic Iodinated Contrast Agents.
    Spampinato MV; Abid A; Matheus MG
    Magn Reson Imaging Clin N Am; 2017 Nov; 25(4):697-704. PubMed ID: 28964459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Selection of contrast media: current status of understanding].
    Briguori C
    G Ital Cardiol (Rome); 2009 Feb; 10(2):79-87. PubMed ID: 19348144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of nonionic, low-osmolality radiocontrast agents with ionic, high-osmolality agents during cardiac catheterization.
    Barrett BJ; Parfrey PS; Vavasour HM; O'Dea F; Kent G; Stone E
    N Engl J Med; 1992 Feb; 326(7):431-6. PubMed ID: 1732770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New and old contrast agents: pharmacology, tissue opacification, and excretory urography.
    Spataro RF
    Urol Radiol; 1988; 10(1):2-5. PubMed ID: 3043872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clotting issue: etiologic factors in thromboembolism. I. Chemistry, pharmacology, and toxicity of angiographic contrast agents.
    Dawson P
    Invest Radiol; 1993 Nov; 28 Suppl 5():S25-30. PubMed ID: 8282499
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.